Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Withdrawn 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Melanoma 23Neoplasm Metastasis 11Leukemia, Myeloid, Acute 11Pancreatic Neoplasms 7Ovarian Neoplasms 7Carcinoma, Renal Cell 7Leukemia 6Kidney Neoplasms 6Breast Neoplasms 6Uterine Cervical Neoplasms 5Stomach Neoplasms 5Lymphoma 5Carcinoma, Non-Small-Cell Lung 5Neuroblastoma 4Leukemia, Lymphocytic, Chronic, B-Cell 4Colonic Neoplasms 4Rectal Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Lymphoma, Follicular 3Leukemia, Myelomonocytic, Chronic 3Gastrointestinal Neoplasms 3Congenital Abnormalities 3Vulvar Neoplasms 2Vaginal Neoplasms 2Uveal Melanoma 2Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2

Interventions

selpercatinib 2pembrolizumab 2130-nm albumin-bound paclitaxel 2vandetanib 1trametinib 1sapanisertib 1repotrectinib 1regorafenib 1pralsetinib 1methyl N-acetylsibirosaminide 1lenvatinib 1fludarabine 1cemiplimab 1alectinib 1aldesleukin 1Thyrotropin Alfa 1Presenilin-1 1Panitumumab 1Interleukin-15 1Imatinib Mesylate 1IT-101 1IFL protocol 1Gemcitabine 1Dacarbazine 1Cyclophosphamide 1Clinical Trials, Phase II as Topic 1Cetuximab 1Capecitabine 1Camptothecin 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Thyroid Neoplasms × aldesleukin × Clear all
NCT02390739 2019-12-16

Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing Human Thyroglobulin to People With Thyroglobulin Expressing Thyroid Cancer

National Institutes of Health Clinical Center (CC)

Phase 1/2 Withdrawn
Head & Neck

Neoplasm Metastasis, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡